Executive Summary ..................................5
SWOT Analysis..........................................6
Oman Pharmaceuticals And Healthcare Industry SWOT ............................... 6
Oman Political SWOT ................................. 7
Oman Economic SWOT ............................... 7
Oman Business Environment SWOT............ 8
Pharmaceutical Business Environment Ratings .......................................9
Table: Middle East And Africa (MEA) – Regional Pharmaceutical Business Environment Ratings for Q110 ... 9
Limits Of Potential Returns........................ 10
Risks To Realisation Of Returns ................ 10
Oman - Market Summary........................12
Regulatory Regime..................................13
Recent Regulatory Developments .............. 14
Intellectual Property Regime ..................... 15
Table: Current IP Laws In Oman .............. 15
Pricing And Reimbursement ...................... 15
Regional Price Harmonisation .................. 16
Pharmaceutical Industry Developments ....................................................... 16
Free Trade Agreements.............................. 17
Industry Developments...........................19
Epidemiology............................................. 19
Table: Oman Mortality Indicators, 2006 ...................................................... 20
Healthcare Sector ...................................... 21
Table: Number Of Health Centres In Oman, By Region ............................... 21
Table: Number And Type Of Health Institutions In Oman............................ 21
Private Healthcare Sector.......................... 22
Healthcare Funding................................... 24
Healthcare Reforms ................................... 25
Table: Healthcare Reform Targets ............ 25
Medical Tourism........................................ 26
International Healthcare Collaboration ....................................................... 27
International Pharmaceutical Collaboration................................................ 27
Table: India’s Export Of Pharmaceutical Products To GCC Countries (US$mn)............................................ 28
Research And Biotechnology ..................... 28
Medical Devices......................................... 29
Industry Forecast Scenario .....................31
Overall Market Forecasts .......................... 31
Key Growth Factors – Industry.................. 32
Key Growth Factors – Macroeconomic ........................................................ 33
Table: Oman – Economic Activity, 2007-2013 ............................................. 35
Prescription Drug Market Forecast........... 36
Patented Market Forecast.......................... 37
Generic Drug Market Forecast.................. 38
OTC Drug Market Forecast....................... 39
Pharmaceutical Trade Forecast ................ 40
Other Healthcare Data Forecasts.............. 41
Key Risk To BMI’s Forecasts..................... 42
Competitive Landscape..........................43
Pharmaceutical Sector............................... 43
Table: Registered Pharmaceutical Companies And Products....................... 43
Domestic Industry...................................... 43
Foreign Industry ........................................ 44
Recent Industry Developments................... 44
Company Monitor....................................45
Multinationals................................................. 45
Novartis ..................................................... 45
Johnson & Johnson.................................... 47
Indigenous Manufacturers .............................. 48
Zynova/Oman Pharmaceutical Products (OPP)........................................... 48
National Pharmaceutical Industries (NPI) ................................................... 51
BMI Methodology ....................................53
Country Snapshot: Oman Demographic Data ................................................... 53
Section 1: Population................................. 53
Table: Demographic Indicators, 2005-2030................................................. 53
Table: Rural/Urban Breakdown, 2005-2030 ................................................ 54
Section 2: Education And Healthcare........ 54
Table: Education, 2002-2005 .................... 54
Table: Vital Statistics, 2005-2030.............. 54
Section 3: Labour Market And Spending Power ........................................... 55
Table: Employment Indicators, 1999-2004................................................... 55
Table: Consumer Expenditure, 2000-2012 (US$) ......................................... 55
How We Generate Our Pharmaceutical Industry Forecasts ......................... 56
Pharmaceutical Business Environment Ratings Methodology ....................... 57
Ratings Overview....................................... 57
Table: Pharmaceutical Business Environment Indicators ............................ 58
Weighting................................................... 59
Table: Weighting Of Components.............. 59
Sources ........ 59
Forecast Tables .......................................60